Investigators have found no differences in the frequency of CD4+CD25hi Treg cells between patients with MS and healthy controls, while several groups revealed how CD4+CD25hi Treg cells in MS patients are functionally impaired (128–131). The gene discussed is CD4; the disease is myeloid sarcoma.